---
figid: PMC7889969__fcell-09-583572-g0006
figtitle: Schematic mechanism of DOX chemoresistance in ERAlpha-positive breast cancer
  cells
organisms:
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
- Bellapiscis medius
organisms_ner:
- Mus musculus
- Homo sapiens
- Danio rerio
pmcid: PMC7889969
filename: fcell-09-583572-g0006.jpg
figlink: pmc/articles/PMC7889969/figure/F6/
number: F6
caption: A schematic mechanism of DOX chemoresistance in ERα-positive breast cancer
  cells. In ERα-positive breast cancer cells, DOX treatment switches on ERα-mediated
  EMT pathway. Through ERα, DOX increases EMT key transcription factors, Snail and
  Twist, resulting in the decrease of E-cadherin and promoting EMT in ERα-positive
  breast cancer cells. Cells undergoing EMT exhibit DOX-resistance.
papertitle: Estrogen Receptor α Mediates Doxorubicin Sensitivity in Breast Cancer
  Cells by Regulating E-Cadherin.
reftext: Xiaoqing Wan, et al. Front Cell Dev Biol. 2021;9:583572.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9591177
figid_alias: PMC7889969__F6
figtype: Figure
redirect_from: /figures/PMC7889969__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7889969__fcell-09-583572-g0006.html
  '@type': Dataset
  description: A schematic mechanism of DOX chemoresistance in ERα-positive breast
    cancer cells. In ERα-positive breast cancer cells, DOX treatment switches on ERα-mediated
    EMT pathway. Through ERα, DOX increases EMT key transcription factors, Snail and
    Twist, resulting in the decrease of E-cadherin and promoting EMT in ERα-positive
    breast cancer cells. Cells undergoing EMT exhibit DOX-resistance.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Esr1
  - Eral1
  - Twist1
  - Snai1
  - Cdh1
  - Fzr1
  - Itk
  - Slc22a3
  - ESR1
  - ERAL1
  - TWIST1
  - SNAI1
  - CDH1
  - FZR1
  - ITK
  - SLC22A3
  - esr1
  - snai1a
  - cdh1
  - si:busm1-180o5.1
  - si:busm1-180o5.2
  - Doxorubicin
  - Breast cancer
---
